Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Title
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
Authors
Keywords
remdesivir, SARS-CoV-2, RNA-dependent RNA polymerase, COVID-19 treatment
Journal
MOLECULAR CELL
Volume 81, Issue 7, Pages 1548-1552.e4
Publisher
Elsevier BV
Online
2021-01-29
DOI
10.1016/j.molcel.2021.01.035

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now